Michael Cullen - Concepedia

Author

Michael Cullen

Queen Elizabeth Hospital Birmingham

Also Known As

Michael Cullen, Michael H Cullen, Michael H. Cullen

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Queen Elizabeth Hospital Birmingham University Hospitals Birmingham NHS Foundation Trust University of Birmingham Institute of Cancer Research Beatson West of Scotland Cancer Centre

About

Michael Cullen is an author at Queen Elizabeth Hospital Birmingham specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	530
2	Health Sciences	1	1	28
3	Natural Sciences	1	1	125
4	Nursing	1	1	28
5	Biochemistry	1	1	125

Michael Cullen

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas Michael Cullen, Neil Steven, Lucinda Billingham, New England Journal of Medicine	2005	421
Gefitinib Versus Vinorelbine in Chemotherapy-Naïve Elderly Patients With Advanced Non–Small-Cell Lung Cancer (INVITE): A Randomized, Phase II Study Lucio Crinò, Federico Cappuzzo, Petr Zatloukal, Journal of Clinical Oncology	2008	217
Comparison of ABVD and Alternating or Hybrid Multidrug Regimens for the Treatment of Advanced Hodgkin's Lymphoma: Results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519) Peter Johnson, John Radford, Michael Cullen, Journal of Clinical Oncology	2005	135
P-glycoprotein possesses A 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site David R. Ferry, Michael A. Russell, Michael Cullen Biochemical and Biophysical Research Communications Drug TargetBiochemistryFunctional SelectivityMedicineNatural Sciences	1992	125
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR) Michael J. Seckl, Christian H. Ottensmeier, Michael Cullen, Journal of Clinical Oncology MedicineCancer ManagementPhase IiiPharmacologyClinical Trials	2017	111
Consolidation Radiotherapy in Patients With Advanced Hodgkin's Lymphoma: Survival Data From the UKLG LY09 Randomized Controlled Trial (ISRCTN97144519) Peter Johnson, Matthew R. Sydes, Barry W. Hancock, Journal of Clinical Oncology	2010	84
Pharmacokinetic Study of Single Doses of Oral Fludarabine Phosphate in Patients With “Low-Grade” Non-Hodgkin's Lymphoma and B-Cell Chronic Lymphocytic Leukemia James M. Foran, David Oscier, Jennifer Orchard, Journal of Clinical Oncology	1999	69
Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: A randomised, controlled trial Michael Cullen, D.A.L. Morgan, Walter M. Gregory, Cancer Chemotherapy and Pharmacology MedicinePathologyMaintenance ChemotherapyBronchial NeoplasmCancer Treatment	1986	67
Rational Selection of Patients for Antibacterial Prophylaxis After Chemotherapy Michael Cullen, Lucinda Billingham, Claire Gaunt, Journal of Clinical Oncology	2007	57
The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis Michael Cullen, Robert Huddart, Johnathan Joffe, European Urology	2020	55

Page 1